 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients |
| Charlyne Brakta, Alain Stépanian, Peggy Reiner, Maxime Delrue, Mikaël Mazighi, Emmanuel Curis, Virginie Siguret |
|
J Stroke. 2023;25(1):126-131. Published online January 3, 2023 DOI: https://doi.org/10.5853/jos.2022.03034 |
|
Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients Journal of Stroke. 2023;25(1):126-131  Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels Thrombosis Research. 2022;215:1-4 Using a low–molecular weight heparin–calibrated anti–factor Xa assay to assess the concentration of apixaban and rivaroxaban International Journal of Laboratory Hematology. 2021;44(1):163-167 Comparison of Commercial Low Molecular Weight Heparin and Homemade Anti-Xa Calibrators to a Commercial Specific Anti-Xa Calibrator for Plasma Rivaroxaban Quantification by Anti-Xa Oral Anticoagulant Plasma Concentration Chromogenic Assay Laboratory Medicine. 2022;54(4):400-405 Anti-Xa levels with low molecular weight heparin calibrator can be used to exclude significant apixaban effect Pathology. 2019;51(7):768-769 Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban Aterotromboz = Atherothrombosis. 2020;(2)96-104 Effect of 3.2 vs.
3.8% sodium citrate concentration on anti-Xa levels for patients on therapeutic low molecular weight heparin Clinical & Laboratory Haematology. 2003;25(5):317-319 Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban? Transfusion and Apheresis Science. 2016;55(2):212-215 Low molecular weight heparin versus aspirin for acute ischemic stroke: A systematic review Journal of Stroke and Cerebrovascular Diseases. 2002;11(2):55-62 DEVELOPMENT AND VALIDATION OF A NOMOGRAM FOR PREDICTING STROKE‐ASSOCIATED PNEUMONIA IN PATIENTS WITH ACUTE ISCHEMIC STROKE Respirology. 2019;24(S2):23-23 |
